Immune system dysregulation in uremia: Role of oxidative stress

Blood Purification

Volumn 20, Issue 5, 2002, Pages 481-484

  Descamps Latscha, Béatrice ^a   Jungers, Paul ^a   Witko Sarsat, Véronique ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Advanced oxidation protein products; Chronic renal failure; Hemodialysis; Immune dysregulation; Inflammation; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; AMYLOID; ANTIOXIDANT; AUTOANTIBODY; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CD14 ANTIGEN; CD16 ANTIGEN; CD23 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MYELOPEROXIDASE; NEOPTERIN; OXIDIZING AGENT; PROTEIN DERIVATIVE; PROTEIN SYNTHESIS INHIBITOR; PROTEINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; UREMIC TOXIN;

ARTHROPATHY; ATHEROSCLEROSIS; B LYMPHOCYTE ACTIVATION; CELL ACTIVATION; CHRONIC INFLAMMATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE COURSE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; KIDNEY FAILURE; MEDIATOR; MONOCYTE; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UREMIA; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HUMANS; IMMUNE SYSTEM; INFLAMMATION; OXIDATIVE STRESS; UREMIA;

EID: 0036039328     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063558     Document Type: Conference Paper

References (22)

1. The immune system in end-stage renal disease
2. Uremic toxicity: Present state of the art
3. Immune system dysregulation in uremia
4. Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules
5. Chronic inflammation in hemodialysis: The role of contaminated dialysate
6. Dialysis-induced oxidative stress: Biological aspects, clinical consequences, and therapy
7. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure
8. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients
9. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients
10. Cytokines: Agents provocateurs in hemodialysis?
11. Immunological and chronic inflammatory abnormalities in end stage renal disease
12. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
13. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes
14. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure
15. Impairment of antioxidant defense mechanisms in elderly women without increase in oxidative stress markers: 'A weak equilibrium'
16. Tuberculosis in children undergoing continuous ambulatory peritoneal dialysis
17. Importance of oxidatively modified proteins in chronic renal failure
18. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
19. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure
20. Reactive carbonyl compounds related uremic toxicity ('carbonyl stress')
21. Novel targets for interleukin 18 binding protein